1 article
The FDA has issued a class-wide warning for GLP-1 drugs following reports of sudden vision loss. This deep dive examines the data from 134,253 patients and the …
We use analytics cookies to understand how the site is read. Necessary cookies are always on. Learn more
We use cookies to operate the site and, with your consent, to measure how it is used. You can change your choice at any time.
Essential for the site to work — security and remembering your cookie choice. Always active.
Anonymised statistics about page visits, helping us improve the site (Google Analytics).
